# Bristol-Myers Squibb Company (BMY) — Q3-2020 Earnings Results

**Report date:** 2020-11-05 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q3-2020

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Down 2.57%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.63 | N/A | +9.62% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding their future prospects. They emphasized their commitment to innovation despite current market conditions.

**Key quotes:**

> Management highlighted the strength of their pipeline and ongoing research efforts.

> They acknowledged challenges in the current market but expressed confidence in long-term growth.

### Guidance Changes

No guidance updates were provided during the call.

### What It Means

Bristol Myers Squibb's earnings report showed a strong EPS performance, exceeding expectations. However, the stock declined by 2.57% following the announcement, likely due to the lack of revenue data and guidance. Investors may be concerned about the company's future growth potential without clearer direction.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q3-2020_